An immunocytochemical study of calpain II in the hippocampus of rats injected with kainate

Experimental Brain Research

Volumn 113, Issue 1, 1997, Pages 117-129

  Ong, W Y ^a   Garey, L J ^b   Tan, K K ^c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Calpain II; Hippocampus; Kainate

Indexed keywords

AMYLOID; CALPAIN; KAINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DENDRITE; ELECTRON MICROSCOPY; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; MALE; MITOCHONDRIAL MEMBRANE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; TIME;

ANIMALS; CALPAIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KAINIC ACID; MALE; MICROINJECTIONS; MICROSCOPY, ELECTRON; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE; REFERENCE VALUES;

EID: 0031037131     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02454147     Document Type: Article

References (43)

1. Arai A, Kessler M, Lee K, Lynch G (1990) Calpain inhibitors improve the recovery of synaptic transmission from hypoxia in hippocampal slices. Brain Res 532:63-68
2. Banik NL, Hogan EL, Powers JM, Smith KP (1986) Proteolytic enzymes in experimental spinal cord injury. J Neurol Sci 73: 245-256
3. +. J Biol Chem 240:3473-3478
4. Blaschke M, Keller BU, Rivosecchi R, Hollmann M, Heinemann S, Konnerth A (1993) A single amino acid determines the subunit-specific spider toxin block of alpha-amino-3-hydroxy-5-methylisoxuzole-4-propionate/kainate receptor channels. Proc Natl Acad Sci USA 90:6528-6532
5. Croall DE, Slaughter CA, Wortham HS, Skelly CM, DeOgny L, Moomaw CR (1992) Polyclonal antisera specific for the proenzyme form of each calpain. Biochim Biophys Acta 1121:47-53
6. Dodd PR, Scott HL, Westphalen RI (1994) Excitotoxic mechanisms in the pathogenesis of dementia. Neurochem Int 25:203-219
7. El-Fawal HAN, Ehrich MF (1993) Calpain activity in organophosphorus-induced delayed neuropathy (OPIDN): effects of a phenylalkylamine calcium channel blocker. Ann N Y Acad Sci 679:325-329
8. Gibbons SJ, Brorson JR, Bleakman D, Chard PS, Miller RJ (1993) Calcium influx and neurodegeneration. Ann N Y Acad Sci 679:22-33
9. Gilbert DS, Newby BJ (1975) Neurofilament disguise, destruction and discipline. Nature 256:586-589
10. Glenner GG, Wong CW (1984) Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 122:1131-1135
11. Goodman SR, Zagon IS (1986) The neural cell spectrin skeleton: a review. Am J Physiol 250:347-360
12. 2+-activated protease. J Biol Chem 257:9072-9077
13. Honda T, Hamos J, Nixon RA (1992) Soluble derivatives of APP: a potential relationship to abnormal calpain I activation in Alzheimer brain. Soc Neurosci Abstr 18:733
14. Inomata M, Hayashi M, Nakamura M, Imahori K, Kawashima S (1985) Hydrolytic and autolytic behavior of two forms of calcium-activated neutral protease (CANP). J Biochem 98:407-416
15. Inoue N, Matsukado Y, Goto S, Miyamoto E (1988) Localization of glycogen synthase in brain. J Neurochem 50:400-405
16. Johnson GV, Litersky JM, Jope RS (1991) Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study. J Neurochem 56:1630-1638
17. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-736
18. Kawarabayashi T, Shoji M, Harigaya Y, Yamaguchi H, Hirai S (1991) Expression of APP in the early stage of brain damage. Brain Res 563:334-338
19. Lee KS, Frank S, Vanderklish P, Arai A, Lynch G (1991) Inhibi-tion of proteolysis protects hippocampal neurons from ischemia. Proc Natl Acad Sci USA 88:7233-7237
20. Lehmann A, Isacsson H, Hamberger A (1983) Effects of in vivo administration of kainic acid on the extracellular umino acid pool in the rabbit hippocampus. J Neurochein 40:1314-1320
21. Lowy MT, Wittenberg L, Novotney S (1994) Adrenalectomy attenuates kainic acid-induced spectrin proteolysis and heat shock protein 70 induction in hippocampus and cortex. J Neurochem 63:886-894
22. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer's disease and Down syndrome. Proc Natl Acad Sci USA 82:4245-4249
23. Najm I, El-Skaf G, Massicotte G, Vanderklish P, Lynch G, Baudry M (1992) Changes in polyamine levels and spectrin degradation following kainate-induced seizure activity: effect of difluoromethylornithine. Exp Neurol 116:345-354
24. Nakamura Y, Takeda M, Niigawa H, Hariguchi S, Nishimura T (1992) Amyloid β-protein precursor deposition in rat hippocampus lesioned by ibotenic acid injection. Neurosci Lett 136: 95-98
25. Nixon RA, Saito KI, Cataldo AM, Hamos J, Hamilton D, Honda T, Pope A (1992) Abnormalities of the calpain-calpastatin system in Alzheimer brain. Soc Neurosci Abstr 18:198
26. Nixon RA, Saito KI, Grynspan F, Griffin WR, Katayama S, Honda T, Mohan PS, Shea TB, Beermann M (1994) Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann New York Acad Sci 747:77-91
27. Ong WY, Leong SK, Garey LJ, Reynolds R, Liang AW (1996) An immunocytochemical study of glutamate receptors and glutamine synthetase in the hippocampus of rats injected with kainate. Exp Brain Res 109:251-267
28. Rami A, Krieglstein J (1993) Protective effect of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res 609:67-70
29. Saito K, Elce JS, Hamos JE, Nixon RA (1993) Widespread activation of calcium-activated neutral protease (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 90:2628-2632
30. Sandoval IV, Weber K (1978) Calcium-induced inactivation of microtubule formation in brain extracts. Presence of a calcium-dependent protease acting on polymerization-stimulating microtuble-associated proteins. Eur J Biochem 92:463-470
31. Sato S, Quarles RH, Brady RO (1982) Susceptibility of myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain. J Neurochem 39:97-105
32. Schlaepfer WW, Lee C, Lee VMY, Zimmerman UJP (1985) An immunoblot study of neurofilament degradation in situ and during calcium-activated proteolysis. J Neurochem 44:502-509
33. Seubert P, Larson J, Oliver M, Jung MW, Baudry M, Lynch G (1988) Stimulation of NMDA receptors induces proteolysis of spectrin in hippocampus. Brain Res 460:189-194
34. Shigematsu K, McGeer PL, Walker DG, Ishii T, McGeer EG (1992) Reactive microglia/macrophages phagocytose amyloid precursor protein produced by neurons following neural damage. J Neurosci Res 31:443-453
35. Shimohama S, Suenaga T, Araki W, Yamaoaka Y. Shimizu K, Kimura J (1991) Presence of calpain II immunoreactivity in senile plaques in Alzheimer's disease. Brain Res 558:105-108
36. Siman R, Noszek JC (1988) Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1:279-287
37. Siman R, Noszek JC, Kegerise C (1989) Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J Neurosci 9:1579-1590
38. Siman R, Card JP, Davis LG (1990) Proteolytic processing of β-amyloid precursor by calpain I. J Neurosci 10:2400-2411
39. Suzuki K, Tsuji S, Ishiura S, Kimura Y, Kubota S, Imahori K (1981a) Autolysis of calcium-activated neutral protease of chicken skeletal muscle. J Biochem 90:1787-1793
40. 2+ ions. J Biochem 90:275-278
41. Terry RD, Masliah E, Hansen LA (1994) Structural basis of the cognitive alterations in Alzheimer disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven, New York, pp 179-196
42. Vitto A, Nixon RA (1986) Calcium-activated neutral proteinase of human brain: subunit structure and enzymatic properties of multiple molecular forms. J Neurochem 47:1039-1051
43. Yanagisawa K, Sato S, Amaya N, Miyatake T (1983) Degradation of myelin basic protein by calcium-activated neutral protease (CANP) in human brain and inhibition by E-64 analogue. Neurochem Res 8:1285-1293